Anna Borodovsky

Anna Borodovsky

Company: Alnylam Pharmaceuticals

Job title: Vice President & Director - Research


Harnessing RNAi for the Development of Complement Therapeutics 1:30 pm

Mechanism and properties of Alynlam’s RNA interference drugs Applications of Cemdisiran, a C5 targeting siRNA Exploring RNAi for other complement pathway targetsRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.